Smith Edward F

Smith Edward F is listed in filings as Director at Benitec Biopharma Inc.. This profile follows SEC Form 4 activity through Dec 3, 2025, including 2 public disclosures. Recent filings connect the profile to Benitec Biopharma Inc. (BNTC). The current snapshot covers public activity from Dec 11, 2024 to Dec 3, 2025. Reported amounts are shown as $428.1K to $426.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.